Ilk conditional deletion in adult animals increases cyclic GMP-dependent vasorelaxation

Cardiovasc Res. 2013 Aug 1;99(3):535-44. doi: 10.1093/cvr/cvt131. Epub 2013 May 27.

Abstract

Aims: Integrin-linked kinase (ILK) regulates proliferation, differentiation, cell adhesion, and motility in many cell types and has been related to cancer progression, fibrosis, and vascular diseases. We designed the present study to directly explore the effect of ILK deletion on the regulation of vascular tone through the soluble guanylate cyclase (sGC) /protein kinase G (PKG) pathway in healthy adult mice.

Methods and results: Experiments were carried out using a tamoxifen-inducible CRE-LOX system to conditionally delete the ILK gene in adult mice. Mice lacking ILK expression (cKO) presented increased vascular content and increased activity of sGC and PKG, resulting in a more intense vasodilatory response to a single dose of a nitric oxide (NO) donor [sodium nitroprusside (SNP)] or PKG agonist [8-bromoguanosine 3',5'-cyclic monophosphate sodium salt (8-Br)]. Five minutes after SNP or 8-Br administration the reduction in the systolic arterial pressure was enhanced in cKO mice (SNP WT: -7.4 ± 1.2 mmHG; SNP cKO: -14.0 ± 2.5; 8-Br WT: -2.9 ± 1.5 mmHG; 8-Br cKO: -10.0 ± 3.4 mmHG). ILK deletion restored the vascular response to SNP after chronic oral nitrite administration. In addition, ILK deletion also increased hypotensive SNP effect in angiotensin II-treated animals, suggesting a role for ILK in basal and pathological states.

Conclusion: Deletion of ILK in adult animals increased the vascular response to NO. These findings show, for the first time, a requirement for ILK in regulating sGC-PKG expression in vivo.

Keywords: Cyclic-GMP; Integrin-linked kinase; Nitric oxide; Soluble guanylate cyclase; Vascular reactivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / drug effects
  • Aorta / metabolism
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / metabolism*
  • Cyclic GMP / pharmacology
  • Cyclic GMP-Dependent Protein Kinase Type I / metabolism
  • Guanylate Cyclase / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nitric Oxide Donors / administration & dosage
  • Nitric Oxide Donors / pharmacology
  • Nitroprusside / administration & dosage
  • Nitroprusside / pharmacology
  • Protein Serine-Threonine Kinases / deficiency*
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Soluble Guanylyl Cyclase
  • Vasodilation / drug effects
  • Vasodilation / physiology*

Substances

  • Nitric Oxide Donors
  • Receptors, Cytoplasmic and Nuclear
  • Nitroprusside
  • 8-bromocyclic GMP
  • integrin-linked kinase
  • Protein Serine-Threonine Kinases
  • Cyclic GMP-Dependent Protein Kinase Type I
  • Guanylate Cyclase
  • Soluble Guanylyl Cyclase
  • Cyclic GMP